VI
BOLD

Versor Investments’s Audentes Therapeutics, Inc BOLD Stock Holding History

Versor Investments’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-729,714
Closed -$43.7M – 386
2019
Q4 		$43.7M Buy
+729,714
New +$27.4M 2.21% 20

Versor Investments's BOLD Position: Q1 2020 in Review

Versor Investments sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 729,714 shares — an estimated $43.7M sold.

Versor Investments first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $43.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Versor Investments reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Versor Investments sold 729,714 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $43.7M.
  • Versor Investments first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Versor Investments's Audentes Therapeutics, Inc position peaked at $43.7M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Versor Investments's 13F filing for Q1 2020, filed 28 Apr 2020.